.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Julphar
Federal Trade Commission
Citi
Mallinckrodt
Deloitte
Queensland Health
Moodys
Fish and Richardson
Daiichi Sankyo

Generated: December 14, 2017

DrugPatentWatch Database Preview

TRIPROLIDINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Triprolidine Hydrochloride patents expire, and when can generic versions of Triprolidine Hydrochloride launch?

Triprolidine Hydrochloride is a drug marketed by Alpharma Us Pharms, Halsey, Pharm Assoc, Vitarine, Watson Labs, Ivax Sub Teva Pharms, and Superpharm. and is included in seven NDAs.

The generic ingredient in TRIPROLIDINE HYDROCHLORIDE is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Alpharma Us PharmsTRIPROLIDINE HYDROCHLORIDEtriprolidine hydrochlorideSYRUP;ORAL085940-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SuperpharmTRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEpseudoephedrine hydrochloride; triprolidine hydrochlorideTABLET;ORAL088578-001Feb 21, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
VitarineTRIPROLIDINE HYDROCHLORIDEtriprolidine hydrochlorideTABLET;ORAL085610-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HalseyTRIPROLIDINE HYDROCHLORIDEtriprolidine hydrochlorideSYRUP;ORAL088735-001Jan 17, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pharm AssocTRIPROLIDINE HYDROCHLORIDEtriprolidine hydrochlorideSYRUP;ORAL087514-001Feb 10, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsTRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEpseudoephedrine hydrochloride; triprolidine hydrochlorideTABLET;ORAL085273-001Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsTRIPROLIDINE HYDROCHLORIDEtriprolidine hydrochlorideTABLET;ORAL085094-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Teva
Cantor Fitzgerald
UBS
Healthtrust
Covington
Novartis
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot